Humana Company Profile (NYSE:HUM)

About Humana (NYSE:HUM)

Humana logoHumana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care - NEC
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:HUM
  • CUSIP: 44485910
  • Web:
  • Market Cap: $35.79 billion
  • Outstanding Shares: 144,517,000
Average Prices:
  • 50 Day Moving Avg: $240.60
  • 200 Day Moving Avg: $224.06
  • 52 Week Range: $163.50 - $255.27
  • Trailing P/E Ratio: 20.35
  • Foreward P/E Ratio: 20.27
  • P/E Growth: 1.62
Sales & Book Value:
  • Annual Revenue: $53.87 billion
  • Price / Sales: 0.66
  • Book Value: $75.79 per share
  • Price / Book: 3.27
  • Annual Dividend: $1.60
  • Dividend Yield: 0.6%
  • EBIDTA: $2.66 billion
  • Net Margins: 3.37%
  • Return on Equity: 15.85%
  • Return on Assets: 5.76%
  • Debt-to-Equity Ratio: 0.39%
  • Current Ratio: 1.65%
  • Quick Ratio: 1.65%
  • Average Volume: 1.33 million shs.
  • Beta: 0.91
  • Short Ratio: 3.51

Frequently Asked Questions for Humana (NYSE:HUM)

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, August 17th. Investors of record on Tuesday, August 29th will be given a dividend of $0.40 per share on Friday, October 27th. This represents a $1.60 annualized dividend and a yield of 0.65%. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its Board of Directors has authorized a share repurchase program on Tuesday, April 11th 2017, which permits the company to repurchase $2,250,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 7.3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's management believes its shares are undervalued.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) announced its earnings results on Wednesday, August, 2nd. The company reported $3.49 EPS for the quarter, beating the consensus estimate of $3.08 by $0.41. The company earned $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same period in the prior year, the business posted $2.30 EPS. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Friday, November, 3rd 2017. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY17 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of ~$11.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.15.

Where is Humana's stock going? Where will Humana's stock price be in 2017?

19 brokerages have issued 12-month price targets for Humana's stock. Their forecasts range from $200.00 to $280.00. On average, they expect Humana's stock price to reach $243.44 in the next year. View Analyst Ratings for Humana.

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:

  • Kurt J. Hilzinger, Independent Chairman of the Board
  • Bruce D. Broussard, President, Chief Executive Officer, Director
  • Brian A. Kane, Chief Financial Officer, Senior Vice President
  • Timothy S. Huval, Chief Human Resource Officer, Senior Vice President
  • Brian P. LeClaire, Senior Vice President, Chief Information Officer
  • Sam Deshpande, Senior Vice President, Chief Risk Officer
  • Christopher M. Todoroff, Senior Vice President, General Counsel
  • Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer
  • Jody L. Bilney, Senior Vice President, Chief Consumer Officer
  • Christopher H. Hunter, Senior Vice President, Chief Strategy Officer

Who owns Humana stock?

Humana's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Capital World Investors (9.16%), BlackRock Inc. (7.76%), Vanguard Group Inc. (6.85%), FMR LLC (4.52%), State Street Corp (4.24%) and Capital Research Global Investors (2.70%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Capital World Investors, BlackRock Inc., Third Point LLC, Steadfast Capital Management LP, Prudential Financial Inc., Capital Guardian Trust Co. and Samlyn Capital LLC. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, FMR LLC, Koch Industries Inc., Acadian Asset Management LLC, TIAA CREF Investment Management LLC, Ameriprise Financial Inc., Capital Research Global Investors and UBS Asset Management Americas Inc.. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of Humana stock can currently be purchased for approximately $247.66.

MarketBeat Community Rating for Humana (NYSE HUM)
Community Ranking:  2.3 out of 5 ( )
Outperform Votes:  505 (Vote Outperform)
Underperform Votes:  576 (Vote Underperform)
Total Votes:  1,081
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Humana (NYSE:HUM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $243.44 (1.70% downside)

Analysts' Ratings History for Humana (NYSE:HUM)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/17/2017Morgan StanleyBoost Price TargetOverweight$269.00 -> $276.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetHold$234.00 -> $243.00LowView Rating Details
8/4/2017Jefferies Group LLCReiterated RatingHold$257.00LowView Rating Details
8/3/2017Cantor FitzgeraldReiterated RatingNeutral$200.00 -> $223.00LowView Rating Details
8/3/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$236.00 -> $255.00MediumView Rating Details
8/3/2017Credit Suisse GroupReiterated RatingOutperform$250.00 -> $260.00HighView Rating Details
8/3/2017Piper Jaffray CompaniesBoost Price TargetOverweight$280.00HighView Rating Details
7/14/2017Cowen and CompanyReiterated RatingBuy$230.00LowView Rating Details
7/14/2017Bank of America CorporationBoost Price TargetBuy$270.00 -> $275.00LowView Rating Details
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Buy$275.00MediumView Rating Details
6/9/2017ArgusUpgradeHold -> Buy$260.00LowView Rating Details
6/5/2017Royal Bank Of CanadaReiterated RatingHold$214.00LowView Rating Details
5/30/2017Leerink SwannBoost Price TargetOutperform$250.00 -> $265.00LowView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
1/24/2017Stifel NicolausDowngradeBuy -> Hold$214.00 -> $210.00N/AView Rating Details
1/9/2017Barclays PLCReiterated RatingHold$217.00N/AView Rating Details
12/4/2016Susquehanna Bancshares IncReiterated RatingNeutral$180.00 -> $200.00N/AView Rating Details
11/10/2016J P Morgan Chase & CoUpgradeNeutral -> Overweight$163.00 -> $202.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 -> $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
(Data available from 8/17/2015 forward)


Earnings History for Humana (NYSE:HUM)
Earnings by Quarter for Humana (NYSE:HUM)
Earnings History by Quarter for Humana (NYSE HUM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017$3.25N/AView Earnings Details
8/2/2017Q2 2017$3.08$3.49$13.61 billion$13.53 billionViewListenView Earnings Details
5/3/2017Q1 2017$2.55$2.75$13.61 billion$13.76 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.80 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.36 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.24 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.93 billion$12.22 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.45 billion$11.71 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.65 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Humana (NYSE:HUM)
2017 EPS Consensus Estimate: $10.86
2018 EPS Consensus Estimate: $12.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.07$2.75$2.36
Q2 20174$2.37$3.29$3.00
Q3 20174$3.18$3.44$3.30
Q4 20174$2.05$2.56$2.22
Q1 20181$2.74$2.74$2.74
Q2 20181$3.41$3.41$3.41
Q3 20181$3.58$3.58$3.58
Q4 20181$2.47$2.47$2.47
(Data provided by Zacks Investment Research)


Current Dividend Information for Humana (NYSE:HUM)
Next Dividend:10/27/2017
Annual Dividend:$1.60
Dividend Yield:0.65%
Dividend Growth:3.10% (3 Year Average)
Payout Ratio:13.06% (Trailing 12 Months of Earnings)
13.85% (Based on This Year's Estimates)
13.09% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Humana (NYSE:HUM)

Dividend History by Quarter for Humana (NYSE HUM)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Humana (NYSE:HUM)
Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 99.13%
Insider Trades by Quarter for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)
Insider Trades by Quarter for Humana (NYSE:HUM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2017Bruce D BroussardCEOSell12,000$251.88$3,022,560.00View SEC Filing  
8/10/2017M Todoroff ChristopherVPSell22,935$252.52$5,791,546.20View SEC Filing  
6/28/2017Brian P LeclaireSVPSell4,971$240.00$1,193,040.00View SEC Filing  
5/26/2017Heidi S MargulisVPSell1,500$231.96$347,940.00View SEC Filing  
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.00View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.54View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.40View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.62View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.45View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.51View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.56View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.87View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.36View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.71View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.40View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.64View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.13View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.20View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.80View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.47View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.00View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.00View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.10View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.00View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.00View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.65View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.00View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.00View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.00View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.00View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Humana (NYSE:HUM)
Latest Headlines for Humana (NYSE:HUM)
DateHeadline logoHumana Inc. (HUM) Announces Quarterly Dividend of $0.40 - August 17 at 7:40 PM logoHumana Inc. (HUM) PT Raised to $276.00 - August 17 at 4:54 PM logoSummit Health Signs Medicare Network Agreement with Humana - August 15 at 8:14 PM logoInsider Selling: Humana Inc. (HUM) CEO Sells 12,000 Shares of Stock - August 14 at 10:30 PM logoHumana Inc. (HUM) VP M Todoroff Christopher Sells 22,935 Shares - August 14 at 10:30 PM
News IconHedge funds are dumping healthcare stocks - Business Insider - August 14 at 8:11 PM logoBRIEF-Third Point LLC takes share stake in Blackrock Inc, Alexion Pharmaceuticals - August 12 at 1:09 AM logoAnthem to Exit Obamacare Market in Virginia Next Year - New York Times - August 11 at 8:06 PM logoWhen Success Is About Doing Old Things in New Ways - August 11 at 8:06 PM logoMagellan Health (MGLN) versus Humana (NYSE:HUM) Critical Analysis - August 10 at 2:36 PM logoFY2017 EPS Estimates for Humana Inc. Raised by Analyst (NYSE:HUM) - August 10 at 10:42 AM logoTechnical Snapshots for These Health Care Stocks -- CVS Health, Humana, Molina ... - August 10 at 12:59 AM logoHumana Inc. (NYSE:HUM) Rating Reiterated by UBS AG - August 9 at 10:58 PM logoSee what the IHS Markit Score report has to say about Humana Inc. - August 9 at 7:52 PM logoHumana Inc. Expected to Earn FY2018 Earnings of $12.00 Per Share (NYSE:HUM) - August 9 at 1:42 PM logoTenet Dives After Worse Than Expected Quarter Leads to Lower 2017 Outlook - August 9 at 5:25 AM logoMedicare Advantage helps profits for Humana, other insurers - Louisville Business First - August 8 at 7:20 PM logoHumana, Inc. – Value Analysis (NYSE:HUM) : August 8, 2017 - August 8 at 7:20 PM logoHumana Inc. (NYSE:HUM) Given Consensus Rating of "Hold" by Brokerages - August 8 at 8:50 AM logoThe Zacks Analyst Blog Highlights: Apple, General Motors, Tesla, Northrop Grumman and Humana - August 7 at 7:08 PM logoHumana Inc. (NYSE:HUM) Price Target Raised to $243.00 at Deutsche Bank AG - August 7 at 3:38 PM logoQ3 2017 EPS Estimates for Humana Inc. (HUM) Lifted by Leerink Swann - August 7 at 7:40 AM logoBrokers Issue Forecasts for Humana Inc.'s Q4 2017 Earnings (NYSE:HUM) - August 7 at 7:28 AM logoHumana Inc. (NYSE:HUM) Stock Rating Reaffirmed by Jefferies Group LLC - August 6 at 12:34 AM logoInsurers Think They’ve Found the Perfect Patients for Profits - August 4 at 7:54 PM logoHumana Inc. (NYSE:HUM) to Post FY2018 Earnings of $12.40 Per Share, Leerink Swann Forecasts - August 4 at 5:44 PM logoHumana Inc. (NYSE:HUM) Expected to Announce Quarterly Sales of $13.31 Billion - August 4 at 9:34 AM logoOppenheimer Holdings Analysts Lower Earnings Estimates for Humana Inc. (HUM) - August 4 at 7:42 AM logoHumana Inc. (NYSE:HUM) Forecasted to Post Q3 2017 Earnings of $3.32 Per Share - August 4 at 7:42 AM logoUPDATE 3-Humana shares gain as 2018 Medicare Advantage outlook improves - August 4 at 12:42 AM logoHumana Inc. (HUM) Earns Neutral Rating from Cantor Fitzgerald - August 3 at 7:56 PM logoHumana (HUM) Q2 2017 Results - Earnings Call Transcript - August 3 at 7:41 PM logoEdited Transcript of HUM earnings conference call or presentation 2-Aug-17 1:00pm GMT - August 3 at 7:41 PM logoDrama With Obamacare and Humana Over, Aetna Results ‘Crush’ - August 3 at 7:41 PM logoHumana increases guidance again after strong 2Q earnings - August 3 at 7:41 PM logoAetna's Outlook Improves Amid Obamacare Exit - August 3 at 7:41 PM logoCompany News For August 03, 2017 - August 3 at 7:41 PM logo[$$] Aetna Profit Rises on Better Pricing; Company Raises Outlook - August 3 at 7:41 PM logo[$$] Aetna Profit Rises on Better Pricing, Strategy - August 3 at 7:41 PM logoAetna trumps 2Q expectations after scaling back ACA coverage - August 3 at 11:21 AM logoHumana Inc. (NYSE:HUM) Rating Reiterated by Credit Suisse Group - August 3 at 9:12 AM logoHumana says Obamacare exchange member costs lower than predicted - Reuters - August 2 at 8:13 PM logoHumana's (HUM) Q2 Earnings Beat, Revenues Miss - August 2 at 8:13 PM logoHumana (HUM) Beats Earnings Estimates, Lags Revenues in Q2 - August 2 at 8:13 PM logoHumana says Obamacare exchange member costs lower than predicted - August 2 at 8:13 PM logoHumana Shifts Focus From Obamacare To Medicare And Outlook Improves - August 2 at 8:13 PM logoHumana shares gain as 2018 Medicare Advantage outlook improves - August 2 at 8:13 PM logoHumana beats 2Q profit forecasts - August 2 at 8:13 PM logoApple, Illumina rise; AMC Entertainment, GGP fall - August 2 at 4:34 PM logoHumana Inc. (NYSE:HUM) Issues Quarterly Earnings Results - August 2 at 3:46 PM



Humana (HUM) Chart for Thursday, August, 17, 2017

This page was last updated on 8/17/2017 by Staff